Hello, Guest!
  • Monday, December 23, 2024
Photo Contributor: Barbol/Shutterstock

HHS to Back Emergent BioSolutions’ Ebola Drug Development With Potential $704M Award

Emergent BioSolutions (NYSE: EBS) will further develop a licensed drug against Ebola under a potential 10-year, $704 million contract from the Department of Health and Human Services.

Development services on Ebanga under the contract are valued at $121 million and the award includes a five-year option worth $583 million for the U.S. government to procure the monoclonal antibody product, Emergent said Monday.

The biopharmaceutical company will use the federal funds to scale up its manufacturing process, apply for a supplemental biologics license with the Food and Drug Administration and complete stability research.

Ebanga, developed by Ridgeback Biotherapeutics through a National Institute of Allergy and Infectious Diseases license, is given via a single infusion to exhibit antiviral activity.

HHS’ Biomedical Advanced Research and Development Authority previously awarded funds for the developer to put its anti-Ebola product through late-stage production and regulatory activities.

The FDA cleared Ebanga in December 2020.

Video of the Day

Related Articles

NIH Seeks Proposals for Potential $1B Public Information & Communication Services III Contract Contract Awards

NIH Seeks Proposals for Potential $1B Public Information & Communication Services III Contract

The National Institutes of Health has released a solicitation for the third iteration of the multiple-award Public Information and Communication Services contract. PICS III is a potential five-year, $1 billion indefinite-delivery/indefinite-quantity contract and will be competed as a total small business set-aside program, according to the solicitation notice published Thursday. According to the statement of

Health Agencies Embracing Transformation With 3 Key Contract Opportunities Healthcare IT

Health Agencies Embracing Transformation With 3 Key Contract Opportunities

The healthcare sector is currently undergoing a revolution as it moves to implement new technologies and care strategies that have the potential to transform the ways these organizations operate. For the U.S. government, advancements in healthcare offer numerous opportunities to provide those who rely on public health offerings across the nation with top-notch care. At

How Federal Healthcare Organizations Are Working to Improve Cybersecurity Events

How Federal Healthcare Organizations Are Working to Improve Cybersecurity

In March 2021, President Biden issued an Executive Order calling on federal organizations to strengthen their cyber practices to ensure the security of critical information. Since then, agencies have made strides in the adoption of modern cybersecurity practices, such as zero trust architecture, updated policies and more. For public sector healthcare organizations, improving cyber protections means